Zobrazeno 1 - 10 of 18 pro vyhledávání: '"Monika Liljedahl"'
1
Four-Week Daily Calcipotriene/Betamethasone Dipropionate Foam Is Highly Efficacious in Patients With Psoriasis (PSO-LONG Lead-in Phase)
Autor: Richard B, Warren, Michael, Gold, Melinda, Gooderham, Leon H, Kircik, Jean-Philippe, Lacour, Philip, Laws, Monika, Liljedahl, Charles, Lynde, Marie Holst, Mørch, Wiebke, Sondermann, Diamant, Thaçi
Publikováno v: Journal of Drugs in Dermatology. 20:436-441
Psoriasis is a chronic disease requiring long-term treatment strategies. Optimal strategies should include initial rapid relief of symptoms followed by long-term management to maintain remission. This 4-week open-label phase of a long-term proactive
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd3268c7c68e9ac0419f1bfcfcb4f780
https://doi.org/10.36849/jdd.5728
Zobrazit plný text záznamu
2
Efficacy and safety of proactive treatment with twice-weekly topical Cal/BD foam in patients with plaque psoriasis undergoing HPA-axis testing: a PSO-LONG subgroup analysis
Autor: Jean-Philippe Lacour, Irina Turchin, Marie Holst Mørch, Lyn Guenther, Terri Nutt, Adam Reich, Anna Szponar-Bojda, Stephen K. Tyring, William Philip Werschler, Zygmunt Adamski, Neil S. Sadick, Agnieszka Miasik-Pogodzinska, Charles Lynde, Monika Liljedahl, Kim A. Papp
Publikováno v: The Journal of dermatological treatment. 33(4)
OBJECTIVE In PSO-LONG, long-term proactive management (PAM) of psoriasis with fixed-dose combination calcipotriol 50 µg/g and betamethasone dipropionate 0.5 mg/g (Cal/BD) aerosol foam was superior to conventional reactive management. This post-hoc a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c34b202afeab9ab9165db2c7fda23fc4
https://pubmed.ncbi.nlm.nih.gov/34365872
Zobrazit plný text záznamu
3
Twice-weekly topical calcipotriene/betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial)
Autor: Jean-Philippe Lacour, Amrit Takhar, Jean-Luc Perrot, Charles Lynde, Kim A. Papp, Richard B. Warren, Marie Holst Mørch, Monika Liljedahl, Diamant Thaçi, Andreas Wollenberg, Leon H Kircik, Mark Lebwohl, Linda Stein Gold
Publikováno v: Journal of the American Academy of Dermatology. 84(5)
Topical psoriasis treatment relies on a reactive rather than a long-term proactive approach to disease relapse.Assess long-term efficacy and safety of proactive psoriasis management with twice-weekly calcipotriene 0.005%/betamethasone dipropionate 0.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::902740c0da67df09d9519da69da66118
https://pubmed.ncbi.nlm.nih.gov/32950546
Zobrazit plný text záznamu
5
Traitement d’entretien du psoriasis en plaques par une association fixe de calcipotriol (Cal) à 0,005 % et de dipropionate de bétaméthasone (DB) à 0,064 % sous forme de mousse : résultats d’un essai contrôlé randomisé de phase III
Autor: M. Holst Moerch, J.-P. Lacour, Mark Lebwohl, Charles Lynde, F. Cambazard, Richard B. Warren, Diamant Thaçi, Monika Liljedahl
Publikováno v: Annales de Dermatologie et de Vénéréologie. 147:A341-A342
Introduction Dans le cadre d’un traitement d’entretien de 52 semaines chez des adultes atteints de psoriasis en plaques, une association fixe Cal/DB sous forme de mousse a ete etudiee versus placebo pour evaluer le delai avant la premiere rechute
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::deaacc7304b72bef20d0a5ada43382ff
https://doi.org/10.1016/j.annder.2020.09.530
Zobrazit plný text záznamu
8
Tolérance d’un traitement d’entretien par une association fixe de calcipotriol à 0,005 % (Cal) et de dipropionate de bétaméthasone à 0,064 % (DB) sous forme de mousse chez les patients atteints de psoriasis en plaques : résultats de l’étude PSO-LONG
Autor: J.-P. Lacour, M. Holst Moerch, Mark Lebwohl, Richard B. Warren, Charles Lynde, A.M. Snel Prento, Monika Liljedahl, Diamant Thaçi, F. Cambazard
Publikováno v: Annales de Dermatologie et de Vénéréologie. 147:A342
Introduction Dans le cadre d’un traitement d’entretien de 52 semaines chez des patients atteints de psoriasis en plaques, une etude sur l’association fixe de calcipotriol a 0,005 % (Cal) et de dipropionate de betamethasone a 0,064 % (DB) sous f
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::758cafa3dcc9dcb4d2bbe2e4d7ef50f2
https://doi.org/10.1016/j.annder.2020.09.531
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje